Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dexcom (DXCM) Income from Continuing Operations (2016 - 2026)

Dexcom has reported Income from Continuing Operations over the past 17 years, most recently at 199500000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations rose 89.28% to 199500000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 930400000.0 through Mar 2026, up 73.84% year-over-year, with the annual reading at 836300000.0 for FY2025, 45.14% up from the prior year.
  • Income from Continuing Operations was 199500000.0 for Q1 2026 at Dexcom, down from 267300000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 283800000.0 in Q3 2025 and troughed at 48600000.0 in Q1 2023.
  • The 5-year median for Income from Continuing Operations is 134600000.0 (2024), against an average of 146747058.82.
  • Year-over-year, Income from Continuing Operations skyrocketed 1832.08% in 2022 and then tumbled 50.05% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 91800000.0 in 2022, then surged by 179.19% to 256300000.0 in 2023, then tumbled by 40.81% to 151700000.0 in 2024, then skyrocketed by 76.2% to 267300000.0 in 2025, then dropped by 25.36% to 199500000.0 in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Income from Continuing Operations are 199500000.0 (Q1 2026), 267300000.0 (Q4 2025), and 283800000.0 (Q3 2025).